Evidence-Based Versus Personalized Prostate Cancer Screening: Using Baseline Prostate-Specific Antigen Measurements to Individualize Screening
- PMID: 27325846
- PMCID: PMC5019765
- DOI: 10.1200/JCO.2016.68.2138
Evidence-Based Versus Personalized Prostate Cancer Screening: Using Baseline Prostate-Specific Antigen Measurements to Individualize Screening
Comment on
-
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer.J Clin Oncol. 2016 Aug 10;34(23):2705-11. doi: 10.1200/JCO.2016.66.7527. Epub 2016 Jun 13. J Clin Oncol. 2016. PMID: 27298404 Free PMC article.
References
-
- US Preventive Services Task Force: Final Recommendation Statement. www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatem.... - PubMed
-
- Banerji JS, Wolff EM, Massman JD, III, et al. Prostate needle biopsy outcomes in the era of the U.S. Preventive Services Task Force recommendation against prostate specific antigen based screening. J Urol. 2016;195:66–73. - PubMed
-
- American Urological Association: Early detection of prostate cancer: American Urological Association guideline. http://www.auanet.org/education/guidelines/prostate-cancer-detection.cfm. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
